EULAR Online Course on Rheumatic Diseases

(Final exam each October, free 3rd year extension possible)

• A full 2 year educational training course on the wide range of rheumatic diseases entirely on line,
including in-depth discussions and clinical cases for each module
• About 150 authors – all specialists mainly from Europe.
• 42 modules, with each more than 300 hours of training (some modules are optional)
• Self-evaluation of knowledge after each module, final examination online and certificate by EULAR
if passed

* IDD of this Module is included in EULAR Rheumatic Diseases Textbook.

Module Module Name 2018 IDD 1 2018 IDD 2 2018 IDD 3 2018

1 Diagnostic strategies in Vasculitis: Idiopathic

rheumatology Diagnostic strategy Inflammatory
Myopathy (IIM)

2 Early arthritis: diagnosis Magnetic resonance Pathogenic

and management imaging and mechanisms at
ultrasonography in disease onset in early
early arthritis arthritis

3 Pathogenesis and Measuring disability Cytokines and

clinical aspects of and health-related Rheumatoid arthritis
Rheumatoid arthritis quality of life (hrqol)
in rheumatoid
arthritis (ra)

4 Treatment of The role of health Analgesics, NSAIDS, Local and Non-

Rheumatoid arthritis professionals in the COXIBS and Pharmacological
treatment of Glucocorticoids in the therapeutics in the
rheumatoid arthritis treatment of RA treatment of RA

5 Immunology and the Nod-Like receptors Autoantibodies in

rheumatic diseases as innate sensors rheumatoid arthritis
involved in auto-
inflammatory
disorders

6 Spondyloarthritis: Classification and HLA and the

pathogenesis, clinical diagnosis in early spondyloarthropathies
aspects and diagnosis axial
spondyloarthritis

7 Management of The management of Choice of biologic

Spondyloarthritis acute anterior uveitis DMARDS in relation
associated with to extra-articular
spondyloarthritis manifestations in
spondyloarthritis

EULAR Secretariat | Seestrasse 240 | 8802 Kilchberg | Switzerland

T: +41 44 716 30 30 | F: +41 44 716 30 39
eular@eular.org | www.eular.org
 8 Measuring disease
activity and damage in
inflammatory arthritis
9 Juvenile Idiopathic
Arthritis (JIA)
10 Miscellaneous
inflammatory
arthritides: Adult Still’s
disease, sarcoidosis,
palindromic
rheumatism,
paraneoplastic arthritis,
hypertrophic
osteoarthropathy, point
4 from IDD1
'Paraneoplastic
conditions'
11 Infection and arthritis.
Reactive arthritis,
Lyme, Whipple, HIV,
viral arthritis, Septic
arthritis …
12* Crystal arthropathies
13 Clinical epidemiology -
Critical appraisal of
evidence
14a Genetic aspects of
rheumatic diseases
14b Psychosocial aspects
of the rheumatic
diseases
14c Clinical epidemiology -
Impact of the rheumatic
diseases
EULAR Secretariat | Seestrasse 240 | 8802 Kilchberg | Switzerland
T: +41 44 716 30 30 | F: +41 44 716 30 39
eular@eular.org | www.eular.org
Presentation and Magnetic resonance
interpretation of imaging of synovial
radiographic data and bone
inflammation: A clue to
what drives erosive
progression in RA
Imaging in the Measuring disease
assessment of JIA activity, physical
function and damage
in JIA current clinical
practice
Paraneoplastic Hypertrophic
rheumatic conditions osteoarthropathy
Reactive arthritis - Diagnosis and
treatment of acute treatment of Lyme
and arthritis
prolonged/chronic
arthritis
Essentials of crystal Diagnosis of
detection and Monoarthritis
identification in
Synovial Fluid
Methodological Specific
issues of non- methodological issues
inferiority and with non-
equivalence trials pharmacological
interventions
Pros and cons of a Genetic and
genome wide environmental factors
association studies in the susceptibility to
rheumatoid arthritis
Provider-patient Psychological
relations in management of pain
rheumatology
Disability-adjusted The impact of Lifestyle
life years (DALYS), and Comorbidities on
an overall RA
assessment of
disease burden
 15 Imaging The utility of Imaging of GOUT
ultrasonography in
the management of
Psoriatic Arthritis

16 Connective tissue Treatment of Diagnosis of

diseases: Concepts
and pathogenesis,
overlap syndromes,
mixed CTD and
undifferentiated CTD
raynaud's syndrome pulmonary arterial
in patients with hypertension
UCTD and MCTD

17 Systemic lupus Neuropsychiatric Shrinking Lung

erythematosus: manifestations in Syndrome
pathogenesis, and SLE
clinical features

18 Systemic lupus Treatment of How to translate

erythematosus: systemic lupus treatment
treatment erythematosus recommendations into
during pregnancy daily practice

19* Pregnancy related Management of Preconception

problems in rheumatic pregnancy in the counselling
diseases, including the antiphospholipid
anti-phospholipid syndrome
syndrome

20 Systemic sclerosis Nailfold capillary Pulmonary Articular

microscopy hypertension in involvement in
systemic sclerosis systemic sclerosis

21* Polymyositis, Interstitial lung Myositis and cancer Joint involvement in

dermatomyositis: disease and IIMS: Available data
Inflammatory diseases idiopathic
of muscle and other inflammatory
myopathies myopathy

22 Sjögren's syndrome, Primary and IgG4-related disease

Lympho-proliferation in associated
autoimmune diseases SJOGREN’s
syndrome:

Role of
Autoantibodies

23 Vasculitis and Drug-associated Takayasu’s arteritis

secondary form and vasculitis
mimics

24 ANCA-associated Assessment of The role of biologics in

vasculitis and disease activity and ANCA-associated
polyarthritis nodosa damage in small and vasculitis
medium vessel
vasculitis

25 Behçet's disease, Cardiovascular Biotherapy in Behçet’s

relapsing involvement in disease
polychondritis, eye Behçet’s disease

EULAR Secretariat | Seestrasse 240 | 8802 Kilchberg | Switzerland

T: +41 44 716 30 30 | F: +41 44 716 30 39
eular@eular.org | www.eular.org
 symptoms in rheumatic
diseases

26 Polymyalgia rheumatic Giant cell arteritis GCA and sight loss

(PMR) and Giant Cell with large-vessel
Arteritis (GCA) involvement “How do you prevent a
stroke in the eye” –
way forward

27 Systemic Cardiovascular Current therapies of

consequences of the disease risk in RA AA Amyloidosis
inflammatory process: secondary to
amyloidosis, anaemia, inflammatory
atherosclerosis rheumatic diseases

28 Rheumatic Gaucher’s disease Screening for

manifestations of hereditary
systemic haemochromatosis
diseases/miscellaneous
rheumatic diseases

29a Skin and auto-immune Differential Cutaneous

rheumatic diseases diagnosis of manifestations of
Scleroderma antiphospholipid
syndrome (aps)

29b Molecular and cellular Cytokine-dependent Role of IL-17-IL-23

biology of Rheumatic and cytokine- Axis in AS and
diseases independent Psoriatic Arthritis
pathways of joint
destruction in RA
and their impact on
therapeutic
approaches

29c* Rheumatic Sickle cell disease Epidemiology of

manifestations of musculoskeletal pain
tropical diseases and disability in
communities in
developing countries

30 Osteoarthritis: Erosive Models of

osteoarthritis (OA) Osteoarthritis
pathogenesis, clinical
aspects and diagnosis

31 Osteoarthritis: Exercise for OA Intra-articular injection

treatment of corticosteroid in OA

32 Low back pain and Multi/Inter- Symptomatic lumbar

associated symptoms disciplinary spinal stenosis
approaches to
chronic lumbar back
pain

EULAR Secretariat | Seestrasse 240 | 8802 Kilchberg | Switzerland

T: +41 44 716 30 30 | F: +41 44 716 30 39
eular@eular.org | www.eular.org
 33 Regional Wrist pain related Trigger finger
Musculoskeletal Pain with ligamentous
Syndromes structures:
Scapholunate
Ligament Pathology

34 Generalised pain Do we need new Is reduced sleep

syndromes (including classification criteria quality a purely
Fibromyalgia and for fibromyalgia secondary
chronic fatigue syndrome? phenomenon in
syndrome) fibromyalgia?

35 Osteoporosis: Glucocorticoid- Osteoporosis in

pathogenesis and Induced inflammatory joint
clinical features Osteoporosis (GIO) disorders

36 Osteoporosis: Vitamin D deficiency Atypical femoral

treatment and response to fractures in patients
treatment in on Anti-resorptive
postmenopausal therapy
osteoporosis

37 Other bone diseases: Osteomyelitis Osteogenesis

osteomalacia, Paget's imperfecta in adult
disease, renal patients
osteodystrophy,
osteomyelitis,
osteonecrosis

38a Auto-inflammatory AA Amyloidosis in Interleukin-1 Inhibitors

Syndromes Auto-inflammatory
diseases

38b Systemic Primary Mendelian

manifestations of immunodeficiency susceptibility to
primary immune diseases in mucocutaneous
deficiencies and FAS Rheumatology fungal infections
deficiencies patients: When to
suspect, how to
diagnose, and how
to treat?

38c Malignant bone Cancer treatment- Pharmacologically

diseases (including induced bone loss induced
new concepts and Osteonecrosis of the
therapies as they apply jaw
to rh. dis.)

39 Pain: mechanisms and Analgesia and Peripheral pain

management pregnancy mechanisms in
osteoarthritis

40 Principles of Fibromyalgia Footwear in rheumatic

rehabilitation diseases

EULAR Secretariat | Seestrasse 240 | 8802 Kilchberg | Switzerland

T: +41 44 716 30 30 | F: +41 44 716 30 39
eular@eular.org | www.eular.org
 41 Glucocorticoids Glucocorticoids in Effects of
Pregnancy glucocorticoids on
radiological
progression in early
rheumatoid arthritis

42a Cryoglobulinemia and HCV infection and Current and future

systemic arthritis therapeutic strategies
manifestations of for treating mixed
hepatitis C virus cryoglobulinaemia

42b Cell and gene therapy Gene therapy in Cellular therapy of

in rheumatic diseases rheumatic diseases systemic Sclerosis

42c Neuro-endocrine- Effects of Effects of

immunology oestrogens in Neuroendocrine
chronic immune- immune system
mediated players in Systemic
inflammatory Lupus Erythematosus
rheumatic diseases:
the case of
rheumatoid arthritis

EULAR Secretariat | Seestrasse 240 | 8802 Kilchberg | Switzerland

T: +41 44 716 30 30 | F: +41 44 716 30 39
eular@eular.org | www.eular.org